All In MedTech

Device Trial Radar · NCT05574270

Clinical Investigation of a Small Aperture Extended Depth of Focus Intraocular Lens in Patients With Complex Corneas

Last checked: Nov 19, 2026Latest source record: Dec 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

45

Actual

Start

Jul 12, 2022

Primary completion

Nov 28, 2024

Study completion Nov 28, 2024

Sponsor

Lead sponsor
AcuFocus, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 10, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the clinical outcomes of the IC-8 IOL implanted in patients with complex corneas after crystalline lens removal.

Conditions

  • Cataract
  • Presbyopia
  • Irregular Astigmatism

Interventions

  • IC-8 Intraocular Lens (IOL)Device

    A small aperture extended depth of focus hydrophobic acrylic intraocular lens.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Monocular uncorrected distance visual acuity (UCDVA)Time frame: 4-6 Months
  2. Monocular uncorrected intermediate visual acuity (UCIVA)Time frame: 4-6 Months
  3. Monocular uncorrected near visual acuity (UCNVA)Time frame: 4-6 Months

1 more outcomes with a free account

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • Asian Eye Institute

    Makati City, Philippines

  • Singapore National Eye Centre (SNEC); Singapore Eye Research Institute (SERI)

    Singapore, Singapore

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.